Status:
COMPLETED
Evaluation of a Mobile Direct Observation Therapy (DOT) Approach in Children and Young People With Asthma
Lead Sponsor:
Queen's University, Belfast
Conditions:
Asthma in Children
Eligibility:
All Genders
2-16 years
Phase:
NA
Brief Summary
Mobilte Direct Observation Therapy (MDOT) is a technology has the potential to be a cost effective approach to direct observation of therapy administration, the latter being one of the most accurate m...
Detailed Description
Asthma is the most common chronic disease in childhood. It is defined as a chronic inflammatory disorder of the airways in which many cells and cellular elements promote airway obstruction and hyper-r...
Eligibility Criteria
Inclusion
- Children and young people aged from 2-16 years with apparent partially controlled or uncontrolled DTA. The children will have asthma symptoms despite being prescribed ICS (\> 400 mcg/day for children \< 5 years, 800 mcg/day for children \> 5 years) and a second line therapy such as a LABA, LTRA, or theophylline (Nagakumar and Thomas, 2013).
- One member of the household has access to a smartphone, tablet or other mobile device that is capable submitting a video image to an internet accessible repository. This person must have access to the device for the entire period of the intervention phase (6 weeks) of the study.
Exclusion
- Children whose asthma symptoms are controlled.
- Children and/or parents without access or unwilling to allow use of a suitable mobile device for the study.
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03248895
Start Date
August 1 2015
End Date
September 1 2016
Last Update
August 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.